Oshki Manidoo Center is a licensed substance use treatment provider in Bemidji, MN, listed in the SAMHSA treatment directory. Long term residential treatment is available for people who need more than a short stay. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. It serves children/adolescents, young adults, adults.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsIHS/Tribal/Urban (ITU) funds
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsIHS/Tribal/Urban (ITU) funds
Residential/24-hour residentialLong-term residentialShort-term residentialFederal, or any government funding for substance use treatment programsIHS/Tribal/Urban (ITU) funds